Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Universidad de Granada, Spain.
Eur J Med Chem. 2012 Apr;50:129-39. doi: 10.1016/j.ejmech.2012.01.047. Epub 2012 Feb 1.
The synthesis of new compounds with a 1,3,4-thiadiazole structure, and their in vitro biological evaluation as inhibitors of both neuronal and inducible Nitric Oxide Synthase (nNOS and iNOS) is described. These compounds have been designed by an isosteric modification of a series of 4,5-dihydro-1H-pyrazole derivatives, previously described as the nNOS inhibitors. The insertion of the S atom in the heterocyclic ring induces a selective inhibition of the iNOS isoform. Some of these compounds show as iNOS inhibition percentage near of 100% at a concentration of 50 μM, and the IC(50) values measured for the more potent compounds are in a range of 20-40 μM.
描述了具有 1,3,4-噻二唑结构的新化合物的合成及其作为神经元型和诱导型一氧化氮合酶(nNOS 和 iNOS)抑制剂的体外生物评价。这些化合物是通过对先前描述为 nNOS 抑制剂的一系列 4,5-二氢-1H-吡唑衍生物进行等排修饰设计的。杂环环中 S 原子的插入诱导 iNOS 同工酶的选择性抑制。这些化合物中的一些在 50 μM 浓度下表现出接近 100%的 iNOS 抑制百分比,而对更有效化合物测量的 IC50值在 20-40 μM 范围内。